Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 50090-4751

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-4751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rabe-str (Rabe Str)

Chemical structure diagram of rabeprazole sodium, showing the arrangement of atoms including pyridine and benzimidazole rings with sodium, sulfur, oxygen, and methoxy groups as components.*

FDA Label Image

Rabe-str2 (Rabe Str2)

A line graph comparing mean heartburn scores over a 28-day study period for three groups: placebo (n=68), Rabeprazole 10 mg (n=64), and Rabeprazole 20 mg (n=67). Heartburn scores range from 0 (none) to 4 (very severe). Rabeprazole groups show a marked decrease in scores after day 0 compared to placebo.*

FDA Label Image

Rabe-str3 (Rabe Str3)

A line graph comparing mean heartburn scores over 28 study days between a placebo group and a Rabeprazole Sodium 20 mg group. The x-axis indicates study days from -14 to 28, and the y-axis shows mean heartburn scores ranging from 0 (none) to 4 (very severe). The Rabeprazole group shows a decrease in scores after day 0 compared to placebo.*

FDA Label Image

Rabe-str4 (Rabe Str4)

A line graph comparing mean heartburn scores over 28 study days between a placebo group and a rabeprazole sodium 20 mg group. The x-axis represents study days from -14 to 28, and the y-axis shows mean heartburn scores ranging from 0 (none) to 4 (very severe). The graph shows a reduction in heartburn scores after day 0, with the rabeprazole group consistently scoring lower than the placebo group.*

FDA Label Image

Label Image (Lbl500904751)

Label for Rabeprazole Sodium 20 mg delayed-release tablets by A-S Medication Solutions. The label includes the product NDC 50090-4751, storage instructions to store at 77 degrees Fahrenheit and protect from moisture, and indicates a package quantity of 30 tablets. Dosage instructions advise consulting the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.